Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG

Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG →

Boehringer Ingelheim announced today that it has acquired Evax AG, a Swiss biotech company focused on equine health. Founded more than a decade ago at the University of Zurich, Evax has been exploring the use of therapeutic vaccines to addr…